MAPT and Alzheimer disease: As the strongest genetic risk factor for late-onset AD [59], APOE ε4 exacerbates amyloid-beta accumulation, tau pathology, neuroinflammation, and age-related cognitive decline, contributing to neurodegeneration [60,61].